$21.00
+2.58 (+14.01%)
Open$20.72
Previous Close$18.42
Day High$21.60
Day Low$19.04
52W High$26.22
52W Low$10.07
Volume—
Avg Volume1.16M
Market Cap1.19B
P/E Ratio347.45
EPS$0.20
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 40.28M | 37.62M | 42.63M |
| Net Income | 5.96M | 6.39M | 5.58M |
| Profit Margin | 14.8% | 17.0% | 13.1% |
| EBITDA | 9.95M | 8.49M | 10.51M |
| Free Cash Flow | 4.30M | 2.60M | 2.90M |
| Rev Growth | -6.7% | -3.0% | -1.0% |
| Debt/Equity | 0.89 | 0.84 | 0.78 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $7.86 | -10.68% | — | 5.22B |
| PICS | Pics Nv | $10.49 | -9.22% | — | 1.50B |
| DMII | Drugs Made In America Acquis | $10.03 | +0.00% | 152.6 | 638.91M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.84B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.54 | -0.01% | 62.2 | 606.86M |
| CEPF | Cantor Equity Partners-Cl A | $10.32 | +0.10% | 96.1 | 589.22M |